Oklahoma Board of Nursing updates authority rules for Certified Registered Nurse Anesthetists

House Bill 2298, introduced in the Oklahoma State Legislature on February 25, 2025, aims to enhance the regulatory framework governing Certified Registered Nurse Anesthetists (CRNAs) in the state. The bill seeks to clarify the scope of practice for CRNAs, particularly regarding their authority to order, select, obtain, and administer drugs.

Key provisions of the bill include a requirement for CRNAs to submit a notarized application to the Oklahoma Board of Nursing, along with an established application fee, to maintain their drug administration authority. The bill also stipulates that this authority can be revoked if a CRNA is found to have acted outside their scope of practice or violated relevant state or federal laws. Additionally, the Oklahoma Board of Nursing is tasked with notifying the State Board of Pharmacy of any changes in a CRNA's authority.

The introduction of House Bill 2298 has sparked notable discussions among healthcare professionals and lawmakers. Supporters argue that the bill will streamline the process for CRNAs, allowing them to operate more efficiently within their roles, which is particularly crucial in rural areas where healthcare access is limited. However, some opposition has emerged, with critics expressing concerns about potential overreach and the implications for patient safety.

The economic implications of the bill could be significant, as enhancing the capabilities of CRNAs may lead to improved healthcare delivery and reduced costs in anesthesia services. Socially, the bill could empower CRNAs, allowing them to take on more responsibilities and potentially alleviating some of the burdens on physicians.

As House Bill 2298 moves through the legislative process, its potential to reshape the landscape of anesthesia care in Oklahoma remains a focal point of debate. Stakeholders are closely watching how the bill evolves and what it could mean for the future of nursing practice in the state.